Advancing today’s therapies to enable healthier lives
We are a clinical stage biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases
Proprietary portfolio
Using our Arestat® technology platform, we are developing enhanced therapeutic medicines for the treatment of diabetes and obesity
Partnering
We are partnering with leading pharmaceutical and medtech companies to develop enhanced therapeutic medicines
Validated technology
A business underpinned by the world-leading Arestat® technology platform with a robust intellectual property portfolio
Latest News
-
9th March 2026
Arecor to present at Oppenheimer Annual Healthcare MedTech & Services Conference
-
23rd February 2026
Arecor talks to Biotech TV
-
7th January 2026
Arecor and Sequel Med Tech Fireside Panel Discussion